Programme Committee

Costas Charitidis (Greece)

Costas Charitidis is Professor at the School of Chemical Engineering of NTUA and Director of RNanoLab, est. 2006. He has extensive R&D experience through collaborations with international research centres  in the context of more than 60 projects funded by the European Commission and National funds, in many of them as Coordinator. He is a referee in International scientific journals, evaluator & scientific advisor of R&D projects. He is the author of several scientific books, chapters in international textbooks, and more than 400 scientific publications in peer-reviewed international journals and conference proceedings and his work has received ~7800 citations (h-index 44).

Lisa Bero (USA)

Professor Lisa Bero, Chief Scientist, Center for Bioethics and Humanities, University of Colorado, is a leader in evidence synthesis, meta-research and studying commercial determinants of health, focusing on tobacco control, pharmaceutical policy, and public health.  She is internationally known for her studies on the integrity of research evidence that is used to influence health policy.   She was Co-Chair, Cochrane Governing Board 2014-2018 and is Senior Editor, Research Integrity, Cochrane.  She is affiliate professor, University of Sydney where she founded the Evidence, Policy and Influence Collaborative at the Charles Perkins Centre. Prof. Bero has chaired and served on international committees related to conflicts of interest, evidence and decisions, and evidence synthesis.

Roxana Lescano (Peru)

My experience spans from IRB administration to programme oversight and monitoring, assisting my institution and other institutions in Peru in the development of their institutional policies and educational programmes in areas of human subjects protection, scientific integrity and care and use of animals. I have also been very active supporting the creation of IRBs in Peruvian universities outside of Lima, in compliance with a Peruvian mandate. This has involved training seminars, review of their policies and procedures, and advising them on compliance issues.
Additionally, I have been involved in several scientific integrity training activities for the past 10 years, preparing modules for the original Responsible Conduct of Research Peruvian online course, coordinating curricula for short courses and workshops for local under-graduate and graduate programmes, as well as speaking in various parts of Peru and in neighbouring countries.
Since 2019, I have been a member of the programmatic and planning committee for the organization of the World Conferences of Research Integrity held in Hong Kong in 2019, in Cape Town in 2022 and to be held in Athens, Greece in 2024. 
 I am an attorney and hold a Masters in Bioethics from Universidad Antonio Ruiz de Montoya in Lima, Peru.


Chris Graf (UK)

Chris Graf is the Research Integrity Director at Springer Nature (a position he has held since September 2021) and Leader of the Editorial Excellence Team (since January 2022). In these roles, he is in charge of leading the continued development and implementation of Springer Nature’s research integrity strategy, leading a 30-person team accountable for upholding the highest standards for research integrity in all of Springer Nature’s publications. Chris also serves the publishing sector with a voluntary role at the STM Association, the global trade association for academic and professional publishers, where he chairs a committee of senior publishing industry executives overseeing governance of the STM Integrity Hub. The STM Integrity Hub is an initiative launched early 2022 to equip the publishers (and the scholarly communication community) with data, intelligence, and technology to protect research integrity. In 2023 Chris was appointed to a position as committee member of the UK Committee on Research Integrity, a new organisation hosted by UKRI, that promotes research integrity across the UK and internationally.


David Moher (Canada)

Dr. David Moher is a senior scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute, where he directs the Center for Journalology. Dr. Moher is also a full Professor, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa. Dr. Moher received an MSc in epidemiology and PhD in clinical epidemiology and biostatistics. Dr. Moher is a fellow of the Royal Society of Canada, and Canadian Academy of Health Sciences. Dr. Moher works in knowledge synthesis; predatory journals; reporting guidelines; and open science.

Ana Marušić (Croatia)

Ana Marušić is Professor of Anatomy, Chair of the Department of Research in Biomedicine and Health, and Head of the Center for Evidence-based Medicine at the University of Split School of Medicine, Split, Croatia. She is an Honorary Professor at the University of Edinburgh in the UK. Prof. Marušić was the editor in chief of the Croatian Medical Journal and the Journal of Global Health. She is currently Senior Co-editor in Chief of ST-OPEN. She was the president of several editorial organisations: European Association of Science Editors (EASE), Council of Science Editors (CSE), and World Association of Medical Editors (WAME). She currently serves on the Council of the Committee on Publication Ethics (COPE). Prof. Marušić’s research interest include evidence-based medicine and research integrity. She has published more than 300 peer-reviewed publications and was heavily involved with creating the policy of mandatory registration of clinical trials in public registries which helped change the legal regulation of clinical trials worldwide. She has participated in several EU projects related to research integrity and responsible research and innovation.

Jennifer Byrne (Australia)

Jennifer Byrne is conjoint Professor of Molecular Oncology at the University of Sydney, Australia and Director of Biobanking with New South Wales Health Pathology. Jennifer trained at the University of Queensland and was a postdoctoral fellow in Strasbourg, France. She returned to Sydney to continue her career in laboratory-based cancer research and human tissue biobanking. Jennifer leads the PRIMeR (Publication and Research Integrity in Medical Research) group at the University of Sydney and the New South Wales Statewide Biobank, where she undertakes research and advocacy for transformed research publication standards and error correction capacity.